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diabetes. Rat amylin, which differs from human amylin at six residues, does not lead to formation of amyloid fibrils. Pramlintide is
a synthetic analog of human amylin that shares three proline substitutions with rat amylin. Pramlintide has a much smaller pro-
pensity to form amyloid aggregates and has been widely prescribed in amylin replacement treatment. It is known that the three
prolines attenuate b-sheet formation. However, the detailed effects of these proline substitutions on full-length hIAPP remain
poorly understood. In this work, we use molecular simulations and bias-exchange metadynamics to investigate the effect of pro-
line substitutions on the conformation of the hIAPP monomer. Our results demonstrate that hIAPP can adopt various b-sheet
conformations, some of which have been reported in experiments. The proline substitutions perturb the formation of long
b-sheets and reduce their stability. More importantly, we find that all three proline substitutions of pramlintide are required to
inhibit b conformations and stabilize the a-helical conformation. Fewer substitutions do not have a significant inhibiting effect.INTRODUCTIONAmylin, or islet amyloid polypeptide (IAPP), is a peptide
hormone that is coproduced with insulin by pancreatic
b-cells (1,2). Human IAPP (hIAPP) consists of 37 residues,
with a disulfide bridge between residues 2 and 7. The amy-
loid formation of hIAPP has been closely associated with
the development of type II diabetes (1,3–7). It is believed
that hIAPP amyloid deposits cause the loss of b-cells,
thereby reducing insulin secretion (6,8–10).
Other species, including nonhuman primates, cats, and
the degu, are also known to develop islet amyloid (3,11–
14). In contrast, rat and mouse IAPPs are not amyloidogenic
(15–17). As shown in Fig. 1, rat IAPP (rIAPP) contains 37
residues and differs from hIAPP at only six of these resi-
dues. Hence, rIAPP is often used as a proxy to study the
mechanism and inhibition of hIAPP fibril formation
(18,19). Out of these six residues, rIAPP has three proline
residues, often referred to as b-sheet breakers, that greatly
attenuate fibril formation (16,17). Based on this informa-
tion, pramlintide, a synthetic human amylin analog, was de-
signed to exhibit much reduced amyloidogenic properties.
Pramlintide, also known as symlin, includes three proline
substitutions at residues 25, 28, and 29, as seen in rIAPP
(15,20). It has been used clinically in amylin replacement
treatment for both type I and type II diabetes patients who
take insulin (3,21,22).
Due to its amyloidogenic nature, it is difficult to study the
conformational states of hIAPP in solution. Early in vitro cir-
cular dichroism (CD) studies found that hIAPP is mostly un-
structured (23,24).More recentCDandNMRmeasurements,
however, suggest that hIAPP exhibits a tendency to form an
a-helix at the N-terminus region (residues 5 23), and thatSubmitted April 14, 2013, and accepted for publication July 19, 2013.
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0006-3495/13/09/1227/9 $2.00the C-terminus remains unstructured (25–29). Cort et al.
(30) suggested that both hIAPP and pramlintide form an
a-helix at the N-terminus, with pramlintide exhibiting a
stronger helical content than hIAPP. It is believed that the
N-terminal helix is responsible for receptor binding (1).
Just as the monomer conformation is poorly understood,
little is known about the hIAPP fibril structure. Kajava
et al. (31) proposed a three-strand model, with b-strands
assigned to residues 12 17, 22 27, and 31 37. Luca
et al. (32) used solid-state NMR (ssNMR) to propose a
strand-loop-strand morphology for hIAPP monomers in a
fibril, where residues 8 17 and 28 37 form b-sheets.
Such a morphology is also supported by time-resolved
two-dimensional IR (2DIR) and electron paramagnetic reso-
nance (EPR) studies, with minor differences of one or two
residues in the b-strand assignments (33,34). Wiltzius
et al. (35) utilized fibril structures from the segments of
residues 21 27 and 28 33 and relied on x-ray diffraction
to propose a similar U-shape fibril structure, but with more
closely interdigitated side chains compared with those in-
ferred by ssNMR (32).
The central region of hIAPP, i.e., residues 20 29, can
independently form fibrils. That region has been proposed
to be responsible for hIAPP amyloidogenic properties
(36). The 20 29 fragment also contains five out of the
six differing residues between rIAPP and hIAPP, and it is
often used as a model for studies of amyloid formation
(37). Experiments have shown that one or more proline sub-
stitutions on such fragments at positions 25, 28, and 29
reduce fibril formation, with position 28 being the most crit-
ical (16,17). Additional studies have also demonstrated that
fragments other than the central region, including 8 20,
10 19, 30 37, and 8 37, can form amyloid (38–40).
Proline substitutions outside the central fragment also atten-
uate fibril formation (15,41).http://dx.doi.org/10.1016/j.bpj.2013.07.029
FIGURE 1 Sequence alignment with numbering based on hIAPP for
various hIAPP derivatives, and IAPP of rat and species that form islet
amyloid (11–14). Sequences of hIAPP, pramlintide, and two other hIAPP
mutants are listed above the green dashed line. The proline mutations are
marked with red, underlined fonts. The species variants of IAPP are given
below the green dashed line, with the residues that differ from those in
hIAPP marked in blue, underlined fonts.
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aggregation of hIAPP involves a significant portion of the
peptide, not just individual fragments. With that view in
mind, in this work we investigated the effect of the proline
substitutions encountered in pramlintide on the solution
conformations of IAPP using the full peptide sequence.
Recently, we used molecular dynamics (MD) and Monte
Carlo simulations combined with Fourier-transform infrared
(FTIR) spectrometry to study the conformations of full-
length rIAPP and hIAPP monomers in dilute solution
(42,43). Our data revealed that rIAPP adopts primarily
two conformations: N-terminal a-helix and unstructured
coil. In contrast, hIAPP was found to adopt three conforma-
tional states: N-terminal a-helix, b-hairpin, and unstruc-
tured coil. The b-hairpin conformation was shown to act
as a possible precursor for amyloid formation (43–45).
Simulations and time-resolved 2DIR have also been used
to examine the structure of hIAPP fibrils as well as fibril
formation in mixtures of hIAPP and rIAPP (18,33).
Here, we use MD and Monte Carlo simulations in the
context of an advanced sampling technique, bias-exchange
metadynamics (BE-Meta), to study the conformations of
hIAPP and pramlintide in solution (46). BE-Meta has
been successfully applied to study protein folding and the
nucleation of small amyloid peptides (46–48). We also
explore the conformations of two hIAPP derivatives, one
having a proline substitution at residue 25 (hIAPP[A25P])
and the other having two proline substitutions at positions
28 and 29 (hIAPP[S28P,S29P]), and examine their structural
stability.MATERIALS AND METHODS
Simulation details
Fig. 1 gives the amino acid sequences of hIAPP and the mutants considered
in this work, namely, pramlintide, hIAPP[A25P], and hIAPP[S28P,S29P].
The C-terminal of each peptide was capped with an NH2 group, and a
disulfide bond was formed to link the Cys2 and Cys7 residues. The amino
acid side chains were ionized on the basis of their pKa values, and the re-
sulting peptide had a net positive charge of þ3 at pH 7. The corresponding
chloride ions were added to the simulation box to neutralize the system. AllBiophysical Journal 105(5) 1227–1235peptides were modeled using the GROMOS96 53a6 force field along with
the SPC water model (49–51). Such a combination was shown to provide
agreement with experimental IR spectrum in previous studies of the rIAPP
monomer, and the hIAPP monomer and its aggregates (18,33,42,43). The
cutoff for van der Waals and short-range electrostatic interactions was
9 A˚. Long-range electrostatic interactions were treated with a particle
mesh Ewald sum (52,53). A linear constraint solver was used to keep all
bonds at their respective equilibrium lengths (54). Temperature and pres-
sure were controlled at 298 K and 1 bar using the Nose-Hoover thermostat
and the Parrinello-Rahman barostat, respectively (55–58). All simulations
were performed with an integration time step of 2 fs using the GROMACS
4.5 molecular simulation package (59). The system’s coordinates were
saved every 10 ps for further analysis.Collective variables
The peptide conformation was characterized using the armsd and anti-brmsd
collective variables (CVs) introduced by Pietrucci and Laio (60). The armsd
is defined as
armsd ¼
X
a
nðRMSDÞ; (1)
1 ðRMSD=0:8Þ8
and nðRMSDÞ ¼
1 ðRMSD=0:8Þ12; (2)
where RMSD measures the root mean-square deviations, in angstroms, of
the backbone N, C , C, O, and C atom positions for every six consecutivea b
residues in the peptide from those in an ideal a-helix (i.e., the average a-he-
lical structure from the STRIDE database) (61). The function nðRMSDÞ
switches smoothly between 0 and 1, and armsd sums over all possible six-
consecutive-residue blocks. Larger armsd values indicate more ideal a-heli-
cal blocks. Similarly, the anti-brmsd order parameter measures the RMSD
values of the backbone atoms for every pair of three-residue blocks in the
peptide sequence from those found in an ideal antiparallel b-sheet. Large
anti-brmsd values indicate more antiparallel b-strands in the structure.
For the particular case of hIAPP, we also used the number of native con-
tacts, ncontact, in the a and b structures determined in our previous work (43)
as two additional CVs to improve conformational sampling:
ncontact ¼
Xcontact
i;j
nij; (3)
8>
and nij ¼
>>><
>>>>:
1 for rij%5:5
1

rij  5:5
2:5
2
1

rij  5:5
2:5
8 for rij>5:5 ; (4)
where rij is the distance in angstroms between the Ca atoms of two residuesthat form hydrogen bonds (H-bonds) in the a or b conformations, nij ,
similar to nðRMSDÞ in Eq. 2, is a switching function between 0 and 1,
and ncontact measures the number of Ca contacts of the a or b structures.
The ncontact for the a structure accounts for all the i to iþ4 residual contacts
in the segment comprising residues 7–21. For the b structure, ncontact mea-
sures the Ca contacts between residue pairs (9,34), (10,33), (11,32), (12,31),
(13,30), (14,29), (15,28), (16,27), (17,26), (18,25), and (19,24). For the
other three hIAPP derivatives, due to lack of structural information, no
native contact CVs and only two RMSD CVs were used to sample the pep-
tide conformation.
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Proline Mutations of Human Amylin 1229Note that the main focus of this work is to evaluate the relative free
energies of distinct hIAPP monomer conformations. Previous simulation
studies relied on parallel tempering or replica-exchange techniques to
explore hIAPP monomer conformations (43,44). Such studies revealed
that hIAPP can adopt a-helical, b-hairpin, and random coil structures,
where the antiparallel b-sheet is the main secondary structure in the
b-hairpin conformation. Note that in the hIAPP mature fibril, peptides stack
into in-register parallel b-sheets, not antiparallel ones. To further determine
whether parallel b-sheets arise in the hIAPP monomer, we performed bias-
exchange simulations with additional CVs, including intrapeptide H-bonds,
dihedral angles, and Cg contacts (see Supporting Material). The resulting
free-energy profile as seen in Fig. S1 and Table S1 is consistent with that
presented later in this work, in terms of only armsd and anti-brmsd CVs.
This finding provides additional evidence indicating that the hIAPP mono-
mer by itself does not adopt a parallel b-sheet conformation.0 2 4 6 8 10 12
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FIGURE 2 Convergence of the free-energy profiles for hIAPP, pramlin-
tide, hIAPP[A25P], and hIAPP[S29P,S29P] (from the top to the bottom
row, respectively). The replicas with bias are plotted in the left column,
and the ones with anti- are in the right column. Following the protocol
described by Marinelli et al. (47) and Biarnes et al. (63), the red profile
is the time average within the time interval ðtfill; tall þ tfill=2Þ using Eq. 7,
and the blue one corresponds to the interval ðtall þ tfill=2; tallÞ. The black
profile is the mean of the two parts.BE-Meta simulations
To calculate the peptide conformational free energy with the CVs described
above, we performed BE-Meta simulations (46) using the PLUMED plugin
for GROMACS (62). The free-energy profiles were constructed using the
METAGUI package for VMD (63,64). BE-Meta combines metadynamics
and replica-exchange techniques (65–68) to enhance the sampling of
various CVs. In metadynamics, a time-dependent bias is added to help
the system escape local minima and enhance sampling. The bias added con-
sists of a sum of Gaussian potentials (65):
VGðx; tÞ ¼ W
X
t0%t
exp
 

Xd
i¼ 1
½xi  xiðt0Þ2
2s2i
!
; (5)
where VGðx; tÞ denotes the bias applied to the system at time t and CV
values x ¼ x1; x2;.:xd; d is the number of CVs used to guide the simula-
tion; W and s are the height and width, respectively, of each Gaussian; and
xiðt0Þ is the ith CVat time t0. In this work, W was 0.1 kJ/mol and s was 0.5
for all CVs. Gaussian potentials were deposited every 1 ps. An exchange of
configurations was attempted between two replicas every tex ¼ 10 ps using
Metropolis criteria (46):
pij ¼ min

1; e½ViGðxi ;tÞþVjGðxj ;tÞViGðxj ;tÞVjGðxi;tÞ=kBT

; (6)
where pij is the probability of accepting an exchange between replica i and j,
kB is the Boltzmann constant, T is the temperature, x
x is the CV value in
system x, and VxGðxy; tÞ is the bias of system x corresponding to the CV value
of system y at time t. In this study, for the case of two CVs, four replicas
were employed. No bias was applied to the first replica. In the second
and third replicas, Gaussian potentials were added to the first and second
CVs, respectively. In the fourth replica, the bias acted simultaneously on
both CVs.
After a certain amount of time tfill, most of the free-energy minima of the
system in each replica were filled and VG fluctuated around an average pro-
file. The free energy along the CV, x, can be approximated with the time
average of VGðx; tÞ after tfill (69):
GðxÞ ¼ 1
tall  tfill
Ztall
tfill
dtGðx; tÞ ¼  1
tall  tfill
Ztall
tfill
dtVGðx; tÞ;
(7)
where tall is the total simulation time, and GðxÞ is the system free energy as
a function of x. The convergence of the free-energy profile in each replica
was monitored using the protocol proposed by Marinelli et al. (47) and
Biarnes et al. (63). As illustrated in Fig. 2, we calculated the average freeenergies corresponding to the time intervals ðtfill; tall þ tfill=2Þ and
ðtall þ tfill=2; tallÞ, for the replica with the armsd or anti-brmsd bias using
Eq. 7. For the filling time tall ¼ 200 ns, and the total simulation time
tall ¼ 400 ns, the two average free-energy profiles are within 1 kBT of
each other, indicating that our simulations are converged.
The information from all replicas is combined to evaluate the free energy
along any CVs, x0, using the weighted histogram analysis method (WHAM)
(47,63,70):
Gðx0Þ ¼ kBT ln
0
BBB@
Pk
i
ni
x0
Pk
j
eðf jViðx0ÞÞ=kBT
1
CCCA; (8)
Ztall
Viðx0Þ ¼ 1
tall  tfill
tfill
dtViGðx0; tÞ; (9)
where k denotes the number of replicas, ni
x0 is the number of times the sys-
tem has the CV value x0 in replica i, ViGðx0; tÞ is the biasing potential acting
on the CV value x0 in replica i at time t, and f i represents constants to be
determined via WHAM iterations. This method has been used to study pro-
tein folding as well as short amyloid fibril nucleation (47,48). In this study,
we applied BE-Meta and WHAM to construct the conformational free
energies of hIAPP derivatives along the armsd and anti-brmsd CVs.Peptide conformation and cluster analysis
By monitoring the peptide conformations within the armsd and anti-brmsd
space, we find that the peptide adopts primarily the a structure when
armsd>3 and anti-brmsd<4, the b structure when armsd<3 and anti-brmsd>5,Biophysical Journal 105(5) 1227–1235
1230 Chiu et al.and the g conformation when armsd<2 and anti-brmsd<2. The free-energy
difference between two conformations is thus given by
DGAB ¼ GB  GA ¼ kBT ln
0
BBB@
PB
x
eGðxÞ=kBT
PA
x
eGðxÞ=kBT
1
CCCA; (10)
where the free energy Gi of conformation i is evaluated by integrating the
free energy GðxÞ of the region i in CV space x.
The peptide may adopt different structures in each conformational re-
gion. For example, if the peptide has an anti-brmsd value of 10, the peptide
can form one long antiparallel b-sheet or exhibit several short antiparallel
b-strands. To characterize this structural multiplicity in each conforma-
tional region, we extracted all of the protein conformations within the
region and performed principal component analysis (PCA) on the confor-
mational ensemble (71,72). Based on the projection on the first two modes,
the peptide conformations were grouped into clusters using the K-means
algorithm (73). To characterize the structural similarity within each cluster,
we averaged the observed structures within a cluster and calculated the
RMSDs from that mean structure. The free-energy difference between
two clusters, m and n, can be estimated by
DGmn ¼ Gm  Gn ¼ kBT ln
0
BB@
Pm
U
eGðxUÞ=kBT
Pn
U
eGðxUÞ=kBT
1
CCA; (11)
where U is a conformation in cluster m or n and has CV values of xU, and
GðxUÞ is the corresponding free energy of xU. Combining PCA and Eq. 11,
we further characterized different peptide conformations and their corre-
sponding thermodynamic stability.FIGURE 3 (A) Free-energy surface of hIAPP along the armsd and anti-
brmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions defined
for the a-helix, b-sheet, and random coil conformations are marked with
purple, orange, and white rectangles. (B) The representative peptide confor-
mation for the a-helical region is labeled with a. The five representative b
conformations identified via PCA analysis are labeled as b1–b5. Also
shown are the corresponding free energies and RMSDs from the mean
structures of each conformation. The a-helical and b-sheet conformation
are identified using the STRIDE algorithm, and are colored in dark purple
and light yellow, respectively.Residues Ala-25, Ser-28, and Ser-29 are rep-
resented by a stick model colored in red, blue, and green, respectively. The
images were generated using VMD (64). (C) For hIAPP, b-sheet segments
along the peptide sequence in each b conformation are shown.RESULTS AND DISCUSSION
Human amylin
We used four CVs to sample the conformations of hIAPP:
armsd , anti-brmsd , and the native Ca contacts in the N-termi-
nal a-helix and the b-hairpin structures proposed by
Reddy et al. (43). The resulting free-energy surface along
the armsd and anti-brmsd is shown in Fig. 3 A. We find that
the difference between the free-energy minima of the a
and b conformations is 9.96 kJ/mol, which is lower
than the 0.6 kJ/mol reported by Reddy et al. (43) for
different CVs. Reddy et al. used the distance between two
Ca carbons of a H-bonding pair residues in the folded
structures as CVs. Under this definition, the unfolded
state requires the H-bonding pair residues to exhibit large
separation distances, which in turn implies more extended
conformations of the molecule. In what follows, any
local conformation with low armsd and anti-brmsd values is
considered to be unstructured. Note that such a definition
for an unstructured coil is less restrictive than the one
employed by Reddy et al. The anti-brmsd CV runs over all
possible 3þ 3 combinations among 37 residues of hIAPP,
and thus is able to sample b-sheet conformations other
than the one suggested by Reddy et al. To better estimate
any free-energy differences, we integrated the free energiesBiophysical Journal 105(5) 1227–1235within each region and calculated the corresponding free
energy using Eq. 10. Our results are listed in Table 1. The
g conformation, due to a large conformational ensemble
in the defined CV region, exhibits the lowest free energy,
namely 6:31 kJ/mol lower than the a conformation. The
b conformation has a free energy that is4:04 kJ/mol lower
than the a conformation. Several conformations were
observed in the b region. These conformations contribute
to an overall low free energy of the b region on the free-
energy surface shown in Fig. 3 A.
FIGURE 4 (A) Free-energy surface of pramlintide along the armsd and
anti-brmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions
defined for the a-helix, b-sheet, and random coil conformations are marked
with purple, orange, and white rectangles. (B) The representative peptide
conformation for the a-helical region and the three representative b confor-
mations identified via PCA analysis are labeled as a and b1–b3, respec-
tively, along with the corresponding free energies and RMSDs from the
mean structures. Residues Pro-25, Pro-28, and Pro-29 are represented by
a stick model colored in red, blue, and green, respectively. The structure
color code is the same as in Fig. 3. (C) For pramlintide, b-sheet segments
along the peptide sequence in each b conformation are shown.
TABLE 1 Free-energy difference of a, b, and g conformations
evaluated via Eq. 10 for hIAPP derivatives
a b g
hIAPP  4.04 6.31
Pramlintide  2.91 1.76
A25P  2.93 3.64
S28PþS29P  1.91 2.03
The free-energy difference (kJ/mol) listed is relative to that of the a confor-
mations.
Proline Mutations of Human Amylin 1231To characterize the various b-sheet conformations that
arise, we performed PCA on the peptide conformations cor-
responding to the b region. We identified five b-sheet-rich
conformations, as illustrated in Fig. 3 B, all having average
RMSDs % 5.27 A˚. Fig. 3 C shows the b-strands along the
peptide sequence for each b conformation. Three of the
structures (b1, b2, and b3) exhibit long b-hairpin conforma-
tions. The b1 hairpin is the same as that identified by
Reddy et al. (43), where the turn region consists of residues
20 23. The b2 conformation is similar to b1 but is shifted
by one residue, with the turn region located at residues
19 22. In the b3 conformation, the turn region is shifted
toward the C-terminus and located at residues 24 27,
whereas the N-terminus generally folds into a short helix.
The b4 structure is a collapsed form of b3 and consists of
four short b-sheets with turn regions at residues 18 21,
24 27, and 30 33. The b5 conformation is a four-fold
b-sheet structure with three turn regions located at residues
10 13, 18 21, and 28 31, respectively.
One of the most widely cited structures for the hIAPP
mature fibril is the one proposed by Luca et al. (32) on
the basis of ssNMR, which was further supported by EPR,
2DIR, and x-ray diffraction data (33–35). The b-strands in
the U-shape fibril model are located at residues 8 17
and 28 37, which are consistent with the b-strands
observed in the b1 and b2 conformations reported here.
Kajava et al. (31) proposed a three-fold b-strand amyloid
model of hIAPP with three b-strands assigned to residues
12 17, 22 27, and 31 37, a structure that is similar
to the b5 conformation identified in this work.
As for the a region, the dominant conformation observed
in our simulations is shown in Fig. 3 B: the N-terminus of
the peptide (residues 1–18) forms an a-helix, and the rest
of the molecule adopts an unstructured coil conformation.
Due to the random conformation in the C-terminus, the
RMSD for the a-helical conformation is 7.19 A˚, which is
larger than that of the b conformations. The free energy of
each conformation can be estimated using Eq. 11. Every b
conformation has a free energy that is lower than that of
the a conformation. The b1 conformation is the most
stable, consistent with the results reported by Reddy et al.
(43). All five conformations contribute to an overall lower
free energy in the b region than that of the a region. In
the literature, the a-helical conformation of hIAPP is
considered important for receptor binding, whereas theb-hairpin conformation is viewed as the misfolded state
(26,27,43–45). The free-energy data presented here for
the hIAPP monomer exhibit multiple folded b states, sug-
gesting that various segments in hIAPP have the ability to
form a b-sheet. This observation is consistent with experi-
mental data on fibril formation with different hIAPP frag-
ments (36,38–40).Pramlintide
Pramlintide, or symlin, differs from hIAPP by three proline
mutations at residues 25, 28, and 29, which are known to
attenuate the propensity for fibrillization (15,20). We con-
ducted BE-Meta using armsd and anti-brmsd as CVs to sample
its conformational space. The resulting free-energy profile
as a function of armsd and anti-brmsd is displayed in
Fig. 4 A. Compared with hIAPP, pramlintide exhibits lower
free energies in the a region and higher free energies in the b
region. By simply comparing the free-energy minima, we
find that the b conformation is 0.27 kJ/mol higher than the
a conformation. After integrating the free energy of each
region, as listed in Table 1, we find that the free-energyBiophysical Journal 105(5) 1227–1235
FIGURE 5 (A) Free-energy surface of hIAPP[A25P] along the armsd and
anti- brmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions
defined for a-helix, b-sheet, and random coil conformations are marked
with purple, orange, and white rectangles. (B) The representative peptide
conformation for the a-helical region and the six representative b confor-
mations identified via PCA analysis are labeled as a and b1–b6, respec-
tively, along with the corresponding free energies and RMSDs from the
mean structures. Residues Pro-25, Ser-28, and Ser-29 are represented by
1232 Chiu et al.difference between the a-helix and the b-sheet conforma-
tion is 2:91 kJ/mol. This suggests that the three proline
mutations do inhibit the formation of conformations rich
in b-sheet content. In addition, according to the free-energy
surface, pramlintide can adopt states with armsd>9, indi-
cating that the proline residues also stabilize the a-helix at
the N-terminus.
Similar to the case with hIAPP, we performed PCA to
characterize the pramlintide conformations in the b region.
Three b conformations (b1, b2, and b3) were identified, as
shown in Fig. 4 B, with RMSDs smaller than 6.14 A˚. The b1
conformation has six short b strands, with the proline resi-
dues located at the turn regions. In the b2 conformation,
the peptide forms a long antiparallel b-sheet, with segments
containing no proline residues. The b3 structure consists of
four adjacent antiparallel b strands, similar to the Greek
key motif. As for the a region, one major conformation
is observed in which the segment comprising residues
4 17 forms an a-helix and the rest of the peptide remains
unstructured, similar to the hIAPP a conformation. Among
the three b conformations, the most stable one, b1, has a free
energy that is 2.55 kJ/mol higher than that of the a confor-
mation, indicating that the helical conformation is the most
stable folded structure of pramlintide. This again confirms
that the three proline residues inhibit the formation of
b-sheets and stabilize the a-helix. The b2 conformation
has two b-strands consisting of segments 9 17 and
31 36, which contain no proline residues. This observa-
tion also agrees with experimental data showing that
hIAPP fragments of residues 10 19 and 30 37 exhibit
amyloidogenic properties (38–40). Indeed, Green et al.
(15) showed that although the three proline substitutions
greatly attenuate fibril formation, pramlintide can still
form small amounts of fibrils (and certainly more than
rIAPP). These results are consistent with the existence of
b-rich metastable conformations in pramlintide inferred
from our simulations. Green et al. also showed that the three
nonproline, rat-specific residues, i.e., Arg-18, Leu-23, and
Val-26, modulate the fibril-forming kinetics, highlighting
the importance of these residues in amyloid formation.a stick model colored in red, blue, and green, respectively. The structure
color code is the same as in Fig. 3. (C) For hIAPP[A25P], b-sheet segments
along the peptide sequence in each b conformation are shown.hIAPP[A25P] and hIAPP[S28P,S29P]
To examine the effects of proline mutations, we calculated
the conformational free energies of hIAPP peptide with
one mutation at Ala-25 (hIAPP[A25P]), as well as two
mutations at Ser-28 and Ser-29 (hIAPP[S28P,S29P]). The
free-energy surface along armsd and anti-brmsd for hIAPP
[A25P] is shown in Fig. 5 A. The free-energy differences
among a, b, and g conformations estimated via integration
over distinct regions are listed in Table 1. The b conforma-
tion for A25P has a free energy that is 2.93 kJ/mol lower
than the corresponding a conformation. Although the differ-
ence is smaller than that in hIAPP, the b conformation is still
slightly more favorable. Fig. 5 B displays the six peptideBiophysical Journal 105(5) 1227–1235conformations in the b region of the free-energy map, iden-
tified via PCA and cluster analysis. The most favorable b
conformation, b1, is similar to the b3 conformation of
hIAPP, with the turn region located at residues 24 27.
Its free energy is 4.06 kJ/mol lower than that of the a
conformation. The other conformations, b2 and b3, consist
of four to five short b-stands. The b4 conformation is a
three-fold b-strand structure, whereas b5 and b6 exhibit
four antiparallel b-strands. For conformations b1–b5, the
Pro-25 residue is found at or near the turn region. Also,
among the six b conformations, only b1 has a long hairpin.
Proline Mutations of Human Amylin 1233When contrasted with the three hairpin conformations
observed in hIAPP, this finding suggests that proline indeed
serves as a b-sheet breaker and attenuates long-b-sheet
formation.
The free-energy surface of hIAPP[S28P,S29P] as a func-
tion of armsd and antibrmsd is shown in Fig. 6 A. As shown in
Table 1, the b-sheet region has an overall free energy
of 1.91 kJ/mol relative to the a-helical region. The reduc-
tion of the free-energy difference is more than that observed
for hIAPP[A25P], suggesting that sequential mutations at
Ser-28 and Ser-29 have a larger inhibiting effect on b-sheet
formation for the hIAPP monomer. PCA and cluster analysis
reveal two major b conformations for hIAPP[S28P,S29P], as
shown in Fig. 6 B. The b1 conformation is a three-strand,
antiparallel b-sheet conformation, similar to the b4 con-
formation of hIAPP[A25P]. The b2 conformation is the
most stable for hIAPP[S28P,S29P], with a free energy of
4.08 kJ/mol relative to the a conformation. The b2 confor-
mation is similar to the b3 structure of hIAPP and the b1
structure of hIAPP[A25P] in which the two proline muta-
tions break the long b-hairpin into two pairs of antiparallelFIGURE 6 (A) Free-energy surface of hIAPP[S28P,S29P] along the armsd
and anti- brmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions
defined for a-helix, b-sheet, and random coil conformations are marked
with purple, orange, and white rectangles. (B) The representative peptide
conformation for the a-helical region and the two representative b confor-
mations identified via PCA analysis are labeled as a, b1, and b2, respec-
tively, along with the corresponding free energies and RMSDs from the
mean structures. Residues Ala-25, Pro-28, and Pro-29 are represented by
a stick model colored in red, blue, and green, respectively. The structure
color code is the same as in Fig. 3. (C) For hIAPP[S28P,S29P], b-sheet seg-
ments along the peptide sequence in each b conformation are shown.b-sheets. Although Pro-28 and Pro-29 suppress long-b-sheet
formation, the two b conformations still have favorable
free energies compared with the a-conformation. For both
hIAPP[A25P] and hIAPP[S28P,S29P], the a-helical regions
have one dominant a-conformation, in which residues
4 17 form an a-helix. Because the helical segment does
not include the mutation sites investigated in this study,
the a conformations for all mutated hIAPP monomers are
similar to those found in wild-type hIAPP.
Several experiments have suggested that amylin remains
amyloidogenic upon single-residue proline mutations at res-
idues 25, 28, or 29 (16,17). In addition, the amylin peptides
corresponding to species having one or two prolines, such as
degu (Pro-28 and Pro-29), cat (Pro-29), and hamster (Pro-25
and Pro-29; see Fig. 1), are known to develop islet amyloid
deposits (11–14). Figs. 3–6 C shows the b-sheet segments
along the peptide sequence in each b conformation for the
hIAPP derivative. Due to their cyclic structural nature,
proline residues are found in the turn regions or at the end
of b-strands, acting as b-sheet breakers and inhibiting
long-b-sheet formation. When different b-strand sequences
are compared, the b4 and b5 conformations of hIAPP
[A25P] and the b1 conformation of hIAPP[S28P,S29P]
exhibit strong similarities to the three-strand amyloid model
proposed by Kajava et al. (31). This observation suggests
that hIAPP[A25P] and hIAPP[S28P,S29P] are able to retain
some amyloidogenic characteristics. According to our free-
energy results (Table 1), the b conformation becomes less
favorable as proline mutations are introduced. The consecu-
tive mutations at Ser-28 and Ser-29 have a greater effect
than a single mutation at Ala-25 on b-sheet inhibition. How-
ever, the b conformations are still more favorable than the a
conformations for both hIAPP derivatives. All three proline
mutations in pramlintide are necessary to make the a
conformation more thermodynamically stable than the b
conformations. This observation agrees with experimental
results on the amyloidogenic nature of variants of IAPP cor-
responding to different species. Our results show that the
proline substitutions modulate the conformation of IAPP
monomers because proline reduces the amyloidogenic ten-
dency by suppressing b-sheet formation.CONCLUSIONS
BE-Meta simulations were used to study the conformational
space and the corresponding free energy of several mutants
of IAPP, namely hIAPP, hIAPP[A25P], hIAPP[S28P, S29P],
and pramlintide (hIAPP[A25P, S29P, S29P]). All four
hIAPP derivatives were found to adopt multiple b-sheet
conformations, unstructured coils, and one major a-helical
conformation in which the N-terminus adopts an a-helical
state. Several of the b-rich conformations observed here
are consistent with previous experimental reports.
In one of the possible aggregation mechanisms of hIAPP,
monomers can interconvert between native folded states,Biophysical Journal 105(5) 1227–1235
1234 Chiu et al.e.g., between the a and g conformations and the b-rich
conformations (43–45). The b-conformers can act as the
amyloidogenic precursor by templating the folding of addi-
tional monomers, and promote self-assembly into small
aggregates and subsequent fibril formation. The results pre-
sented here provide insights into the thermodynamic stabil-
ity of distinct folded states, which could serve as precursors
to fibril formation, and may be useful for developing thera-
peutic strategies aimed at inhibiting early-stage aggregation.
Our simulated free energies help explain the tendency
for aggregation (or lack thereof) of the amylin peptides
found in different species. For hIAPP, hIAPP[A25P], and
hIAPP[S28P,S29P], the b-rich states exhibit lower free
energies than the corresponding a-rich conformations. The
[S28P,S29P] mutations are more effective than the A25P
mutation at raising the free energy of the b-rich conforma-
tions. For pramlintide, where all three proline mutations
are introduced, the a-helical conformation becomes more
thermodynamically favorable than the b-rich conforma-
tions. Our combined results indicate that although
[S28P,S29P] mutations are effective at reducing b-sheet for-
mation, one really needs three mutations, namely [A25P,
S29P, S29P], to eliminate hIAPP’s ability to aggregate.
Another possible aggregation mechanism of hIAPP in-
volves the association of two hIAPP a-conformers into
small nuclei (3,74). In future work, the methodology devel-
oped here will be applied to probe the effect of proline mu-
tations on the dimerization of different hIAPP conformers
and to explore the thermodynamics of nuclei formation.SUPPORTING MATERIAL
Supporting material, one figure, one table, and supporting references
are available at http://www.biophysj.org/biophysj/supplemental/S0006-
3495(13)00847-3.
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